Header cover image
  • Investing Ideas
  • /
  • Swedish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Swedish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Results

1

0 new

High return on equity, past performance and sound balance sheet.

1 companies

Saniona

Market Cap: SEK 1.2b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

SANION

SEK 8.95

7D

-3.8%

1Y

130.1%